References
- Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110(6):1723–9. doi:https://doi.org/10.1182/blood-2006-10-053736
- Karimi M, Cohan N. Cancer-associated thrombosis. TOCMJ. 2010;4(1):78–82. doi:https://doi.org/10.2174/1874192401004010078
- Cooke NM, Egan K, McFadden S, Grogan L, Breathnach OS, O’Leary J, Hennessy BT, Kenny D. Increased platelet reactivity in patients with late-stage metastatic cancer. Cancer Med. 2013;2(4):564–70. doi:https://doi.org/10.1002/cam4.86
- Riedl J, Pabinger I, Ay C. Platelets in cancer and thrombosis. Hamostaseologie. 2014;34(1):54–62. doi:https://doi.org/10.5482/HAMO-13-10-0054
- Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis: an overview. Clin Med Insights: Oncol. 2014;8:129–37.
- Grignani G, Maiolo A. Cytokines and hemostasis. Haematologica. 2000;85:967–72.
- Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. JCO. 2009;27(29):4834–8. doi:https://doi.org/10.1200/JCO.2009.22.6324
- Plantureux L, Crescence L, Dignat-George F, Panicot-Dubois L, Dubois C. Effects of platelets on cancer progression. Thromb Res. 2018;164:S40–S47. doi:https://doi.org/10.1016/j.thromres.2018.01.035
- Breet NJ, Sluman MA, van Berkel MAJPJ, van Werkum JW, Bouman HJ, Harmsze AM, Kelder JC, Zijlstra F, Hackeng CM, ten Berg JM. Effect of gender difference on platelet reactivity. Neth Heart J. 2011;19(11):451–7. doi:https://doi.org/10.1007/s12471-011-0189-y
- Yun S-H, Sim E-H, Goh R-Y, Park J-I, Han J-Y. Platelet activation: the mechanisms and potential biomarkers. BioMed Res Int. 2016;2016:1–5. doi:https://doi.org/10.1155/2016/9060143
- Harrison P, Cramer EM. Platelet α-granules. Blood Rev. 1993;7(1):52–62. doi:https://doi.org/10.1016/0268-960X(93)90024-X
- Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol. 2002;3(7):425–30. doi:https://doi.org/10.1016/S1470-2045(02)00789-1
- Goubran HA, Burnouf T, Radosevic M, El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med. 2013;24(5):393–400. doi:https://doi.org/10.1016/j.ejim.2013.01.017
- Lal I, Dittus K, Holmes CE. Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 2013;15(4):207–19. doi:https://doi.org/10.1186/bcr3425
- Taylor ML, Misso NLA, Stewart GA, Thompson PJ. Differential expression of platelet activation markers CD62P and Cd63 following stimulation with PAF, arachidonic acid and collagen. Platelets. 1995;6(6):394–401. doi:https://doi.org/10.3109/09537109509078478
- Murakami T, Komiyama Y, Masuda M, Kido H, Nomura S, Fukuhara S, Karakawa M, Iwasaka T, Takahashi H. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest. 1996;26(11):996–1003. doi:https://doi.org/10.1046/j.1365-2362.1996.2360585.x
- Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, Mayer H, Grau AJ. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33(11):2570–4. doi:https://doi.org/10.1161/01.STR.0000034398.34938.20
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA. Global Cancer Statistics 2018: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;0:1–31.
- Miller E, Lee HJ, Lulla A, Hernandez L, Gokare P, Lim B. Current treatment of early breast cancer: adjuvant and neoadjuvant therapy. F1000Res. 2014;3:198–14. doi:https://doi.org/10.12688/f1000research.4340.1
- Rampurwala MM, Rocque GB, Burkard ME. Update on adjuvant chemotherapy for early breast cancer. Breast Cancer (Auckl)). 2014;8:BCBCR.S9454–133. doi:https://doi.org/10.4137/BCBCR.S9454
- Elomrani F, Zine M, L’annaz S, Ouziane I, Mrabti H, Errihani H, Afif Mohammed M. Management of early breast cancer in older women: from screening to treatment. BCTT. 2015;7:165–71. doi:https://doi.org/10.2147/BCTT.S87125
- Ochwang’i DO, Kimwele CN, Oduma JA, Gathumbi PK, Mbaria JM, Kiama SG. Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya. J Ethnopharmacol. 2014;151(3):1040–55. doi:https://doi.org/10.1016/j.jep.2013.11.051
- Payne S, Miles D. Mechanisms of anticancer drugs. Cell Bio. 2004;1:34–46.
- Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res. 2006;118(5):555–68. doi:https://doi.org/10.1016/j.thromres.2005.10.015
- Falanga A, Marchetti M, Russo L. The mechanisms of cancer-associated thrombosis. Thromb Res. 2015;135:S8–S11. doi:https://doi.org/10.1016/S0049-3848(15)50432-5
- Sandset PM, Hoibraaten E, Eilertsen AL, Dahm A. Mechanisms of thrombosis related to hormone therapy. Thromb Res. 2009;123:S70–S73. doi:https://doi.org/10.1016/S0049-3848(09)70015-5
- Deitcher SR, Gomes MPV. The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma. Cancer. 2004;101(3):439–49. doi:https://doi.org/10.1002/cncr.20347
- Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315–8. doi:https://doi.org/10.1016/j.canep.2009.10.003
- Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48. doi:https://doi.org/10.1016/j.canep.2012.02.007
- Park EJ, Pezzuto JM. Botanicals in cancer chemoprevention. Cancer Metast Rev. 2002;21(3/4):231–55. doi:https://doi.org/10.1023/A:1021254725842
- Moudi M, Go R, Yien CYS, Nazre M. Vinca alkaloids. Int J Prev Med. 2013;4:1231–5.
- Khazir J, Mir BA, Pilcher L, Riley DL. Role of plants in anticancer drug discovery. Phytochem Lett. 2014;7:173–81. doi:https://doi.org/10.1016/j.phytol.2013.11.010
- Priyadarshini K, Keerthi-Aparajitha U. Paclitaxel against cancer: a short review. Med Chem. 2012;2:139–41.
- Zhang S, Sun C, Hu H, He Y, Yao Y, Cao Y, Zeng Z. Effects of Paclitaxel on the ability of aspirin and clopidogrel to inhibit platelet aggregation. Clin Appl Thromb Hemost. 2016;22(7):673–8. doi:https://doi.org/10.1177/1076029615576740
- Kim K, Chang Y-K, Bian Y, Bae O-N, Lim K-M, Chung J-H. Pro-coagulant and pro-thrombotic effects of paclitaxel mediated by red blood cells. Thromb Haemost. 2018;118(10):1765–75. doi:https://doi.org/10.1055/s-0038-1670659
- Chivandi E, Cave E, Davidson BC, Erlwanger KH, Moyo D, et al. Suppression of Caco-2 and HEK-293 cell proliferation by Kigelia africana, Mimusops zeyheri and Ximenia caffra seed oils. In Vivo. 2012;26:99–106.
- Owolabi OJ, Omogbai EKI. Analgesic and anti-inflammatory activities of the ethanolic stem bark extract of Kigelia africana (Bignoniaceae). Afr J Biotechnol. 2007;6:582–5.
- Naidoo D, van Vuuren SF, van Zyl RI, de Wet H. Plants traditionally used individually and in combination to treat sexually transmitted infections in northern Maputaland, South Africa: Antimicrobial activity and cytotoxicity. J Ethnopharmacol. 2013;149(3):656–7. doi:https://doi.org/10.1016/j.jep.2013.07.018
- Bello I, Shehu MW, Musa M, Asmawi MZ, Mahmud R. Kigelia africana (Lam.) Benth.(Sausagetree): phytochemistry and pharmacological review of a quintessential African traditional medicinal plant. J Ethnopharmacol. 2016;189:253–76. doi:https://doi.org/10.1016/j.jep.2016.05.049
- Amusan OOG, Dlamini PS, Msonthi JD, Makhubu LP. Some herbal remedies from Manzini region of Swaziland. J Ethnopharmacol. 2002;79(1):109–12. doi:https://doi.org/10.1016/S0378-8741(01)00381-6
- Zhen J, Guo Y, Villani T, Carr S, Brendler T, Mumbengegwi DR, Kong A-NT, Simon JE, Wu Q. Phytochemical analysis and anti-inflammatory activity of the extracts of the African medicinal plant Ximenia caffra. J Anal Methods Chem. 2015;2015:1–9. doi:https://doi.org/10.1155/2015/948262
- Chivandi E, Davidson B, Pretorius B, Erlwanger K. Proximate, mineral, amino acid, fatty acid, vitamin E, phytate phosphate and fibre composition of Mimusops zeyheri (Red Milkwood) seed. Int J Food Sci Technol. 2011;46(3):555–60. doi:https://doi.org/10.1111/j.1365-2621.2010.02518.x
- Costantini S, Rusolo F, De Vito V, Moccia S, Picariello G, Capone F, Guerriero E, Castello G, Volpe M. Potential anti-inflammatory effects of the hydrophilic fraction of pomegranate (Punica granatum L.) seed oil on breast cancer cell lines. Molecules. 2014;19(6):8644–60. doi:https://doi.org/10.3390/molecules19068644
- Vieira CR, Marques MF, Soares PR, Matuda L, de Oliveira CMA, Kato L, da Silva CC, Guillo LA. Anti-proliferative activity of Pterodon pubescens Benth. seed oil and its active principle on human melanoma cells. Phytomedicine. 2008;15(6-7):528–32. doi:https://doi.org/10.1016/j.phymed.2007.08.003
- Seal S, Chatterjee P, Bhattacharya S, Pal D, Dasgupta S, Kundu R, Mukherjee S, Bhattacharya S, Bhuyan M, Bhattacharyya PR, et al. Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cells. PLoS ONE. 2012;7(10):e47014.: doi:https://doi.org/10.1371/journal.pone.0047014
- Al-Sheddi ES, Farshori NN, Al-Oqail MM, Musarrat J, Al-Khedhairy AA, Siddiqui MA. Portulaca oleracea seed oil exerts cytotoxic effects on human liver cancer (HepG2) and human lung cancer (A-549) cell lines. Asian Pac J Cancer Prev. 2015;16(8):3383–7. doi:https://doi.org/10.7314/APJCP.2015.16.8.3383
- Guo G, Yue L, Fan S, Jing S, Yan LJ. Antioxidant and antiproliferative activities of Purslane seed oil. J Hypertens (Los Angel)). 2016;05(02):218. doi:https://doi.org/10.4172/2167-1095.1000218
- Gomes MN, Augustine TN, Moyo D, Chivandi E. Differential response of breast cancer cell lines to Kigelia africana, Ximenia caffra and Mimusops zeyheri seed oils. S Afr J Bot. 2019;121:463–9. doi:https://doi.org/10.1016/j.sajb.2018.12.017
- Yamasaki M, Motonaga C, Yokoyama M, Ikezaki A, Kakihara T, Hayasegawa R, Yamasaki K, Sakono M, Sakakibara Y, Suiko M, et al. Induction of apoptotic cell death in HL-60 cells by Jacaranda seed oil derived fatty acids. J Oleo Sci. 2013;62(11):925–32. doi:https://doi.org/10.5650/jos.62.925
- Pather K, Dix-Peek T, Duarte R, Chetty N, Augustine TN. Breast cancer cell-induced platelet activation is compounded by tamoxifen and anastrozole in vitro. Thromb Res. 2019;177:51–8. doi:https://doi.org/10.1016/j.thromres.2019.02.027
- Leytin V, Mody M, Semple JW, Garvey B, Freedman J. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: Theoretical consideration and evaluation in thrombin-treated platelet populations. Biochem Biophys Res Commun. 2000;269(1):85–90. doi:https://doi.org/10.1006/bbrc.2000.2255
- Augustine TN, van der Spuy WJ, Kaberry LL, Shayi M. Thrombin-mediated platelet activation of lysed whole blood and platelet-rich plasma: A comparison between platelet activation markers and ultrastructural alterations. Microsc Microanal. 2016;22(3):630–9. doi:https://doi.org/10.1017/S1431927616000854
- Lee AY. Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev. 2002;28(3):137–40. doi:https://doi.org/10.1016/S0305-7372(02)00044-0
- Ruf W. Tissue factor and cancer. Thromb Res. 2012;130:S84–S87. doi:https://doi.org/10.1016/j.thromres.2012.08.285
- Oppelt P, Betbadal A, Nayak L. Approach to chemotherapy-associated thrombosis. Vasc Med. 2015;20(2):153–61. doi:https://doi.org/10.1177/1358863X14568705
- Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9(2):237–49. doi:https://doi.org/10.1111/j.1538-7836.2010.04131.x
- Sedlmayr P, Gro Haupt B, Muntean W. Flow cytometric detection of intracellular antigens. Cytometry. 1996;23(4):284–9. doi:https://doi.org/10.1002/(SICI)1097-0320(19960401)23:4<284::AID-CYTO4>3.0.CO;2-H
- Zarà M, Canobbio I, Visconte C, Canino J, Torti M, Guidetti GF. Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells. Cell Signal. 2018;48:45–53. doi:https://doi.org/10.1016/j.cellsig.2018.04.008
- Mirlashari MR, Ryningen A, Mikkelsen HM, Fukami MH. Differential secretion of blood platelet storage granules. Platelets. 1996;7(5-6):313–20. doi:https://doi.org/10.3109/09537109609023594
- Pather K, Augustine TN. Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo. Sci. Rep. 2020; 19256:2020.
- Bazán-Salinas IL, Matías-Pérez D, Pérez-Campos E, Mayoral LP-C, Ia G-M. Reduction of platelet aggregation from ingestion of oleic and linoleic acids found in Vitis vinifera and Arachis hypogaea oils. Am J Ther. 2015;23:1–5.
- Huerta-Yépez S, Tirado-Rodriguez AB, Hankinson O. Role of diets rich in omega-3 and omega-6 in the development of cancer. Bol Med Hosp Infant Mex. 2016;73(6):446–56. doi:https://doi.org/10.1016/j.bmhimx.2016.11.001
- Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 2008;269(2):363–77. doi:https://doi.org/10.1016/j.canlet.2008.03.044
- Anderson BM, Ma DWL. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009;8(1):33. doi:https://doi.org/10.1186/1476-511X-8-33
- Covington MB. Omega-3 fatty acids. Am Fam Physician. 2004;70:133–40.
- Akiba S, Murata T, Kitatani K, Sato T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biological & Pharmaceutical Bulletin. 2000;23(11):1293–7. doi:https://doi.org/10.1248/bpb.23.1293
- Cohen MG, Rossi JS, Garbarino J, Bowling R, Motsinger-Reif AA, Schuler C, Dupont AG, Gabriel D. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel. Thromb Res. 2011;128(4):335–40. doi:https://doi.org/10.1016/j.thromres.2011.04.023
- DeFilippis AP, Rai SN, Cambon A, Miles RJ, Jaffe AS, Moser AB, Jones RO, Bolli R, Schulman SP. Fatty acids and TxA2 generation, in the absence of platelet-COX-1 activity. Nutr Metab Cardiovasc Dis. 2014;24(4):428–33. doi:https://doi.org/10.1016/j.numecd.2013.08.012
- Holmes CE, Levis JE, Schneider DJ, Bambace NM, Sharma D, Lal I, Wood ME, Muss HB. Platelet phenotype changes associated with breast cancer and its treatment. Platelets. 2016;27(7):703–11. doi:https://doi.org/10.3109/09537104.2016.1171302
- Mangalpally KKR, Siqueiros-Garcia A, Vaduganathan M, Dong J-F, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010;30(3):251–62. doi:https://doi.org/10.1007/s11239-010-0489-x
- Picker SM. In vitro assessment of platelet function. Transfus Apher Sci. 2011;44(3):305–19. doi:https://doi.org/10.1016/j.transci.2011.03.006